Literature DB >> 2627202

Salivary prostaglandin concentrations: possible state indicators for major depression.

S Nishino1, R Ueno, K Ohishi, T Sakai, O Hayaishi.   

Abstract

Salivary prostaglandin concentrations were determined in 42 patients with major depressive disorder, 16 patients with minor depressive disorder, and 39 healthy control subjects. The diagnoses were made according to the Research Diagnostic Criteria. The patients with major depressive disorder had higher salivary prostaglandin concentrations than the control subjects, but the patients with minor depressive disorder did not. Furthermore, the salivary prostaglandin concentrations of the patients with major depressive disorder showed a high correlation with the severity of the depression. These results suggest that high salivary prostaglandin concentrations may be state indicators for major depression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2627202     DOI: 10.1176/ajp.146.3.365

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  26 in total

Review 1.  Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.

Authors:  W Swardfager; M Hennebelle; D Yu; B D Hammock; A J Levitt; K Hashimoto; A Y Taha
Journal:  Neurosci Biobehav Rev       Date:  2018-02-02       Impact factor: 8.989

Review 2.  The inflammation hypothesis in geriatric depression.

Authors:  George S Alexopoulos; Sarah Shizuko Morimoto
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

Review 3.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

Review 4.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

5.  Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis.

Authors:  Sang-Ho Choi; Robert Langenbach; Francesca Bosetti
Journal:  J Neurochem       Date:  2006-06-19       Impact factor: 5.372

Review 6.  Mood-stabilizers target the brain arachidonic acid cascade.

Authors:  Jagadeesh S Rao; Stanley I Rapoport
Journal:  Curr Mol Pharmacol       Date:  2009-06       Impact factor: 3.339

7.  Salivary eicosanoid concentration in patients with Sjögren's syndrome.

Authors:  M Tishler; I Yaron; A Raz; F A Meyer; M Yaron
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

8.  Psychological factors in asthma.

Authors:  Ryan J Van Lieshout; Glenda Macqueen
Journal:  Allergy Asthma Clin Immunol       Date:  2008-03-15       Impact factor: 3.406

Review 9.  Metabolomics Biomarkers for Precision Psychiatry.

Authors:  Pei-An Betty Shih
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Brain lipid concentrations in bipolar disorder.

Authors:  Miki Igarashi; Kaizong Ma; Fei Gao; Hyung-Wook Kim; Deanna Greenstein; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2009-09-19       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.